Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(33 sites) Estonia
North Estonia Medical Centre Foundation, Talinn France
Centre hospitalier d'Avignon, Avignon Germany
Evangelische Lungenklinik Berlin, Buch Ruhrlandklinik Essen, Essen Pius Hospital, University Medicine Oldenburg, Oldenburg Ireland
Beaumont Hospital, Dublin St James's Hospital, Dublin Italy
IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Instituto Europeo di Oncologia (IEO), Milan AOU Maggiore della Carità, Novara Fondazione IRCCS Policlinico S. Matteo, Pavia University of Perugia, AO SM Misericorida Perugia, Perugia Nuovo Ospedale di Prato Santo Stefano, Prato Azienda ospedaliero-universitaria Senese Siena, Siena AULSS2 Marca Trevigiana Treviso, Treviso Azienda Ospedaliera Universitaria Integrata di Verona, Verona Singapore
National University Hospital, Singapore Spain
Complejo Hospitalario Universitario, A Coruña Hospital General Universitario Dr. Balmis de Alicante, Alicante Hospital Universitario Cruces, Barakaldo Hospital de La Santa Creu I Sant Pau, Barcelona Hospital Universitario Vall D'Hebron, Barcelona Hospital Clínico San Cecilio de Granada, Granada Hospital Universitario de Jerez de La Frontera, Jerez de la Frontera Hospital Clínico San Carlos, Madrid Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife Hospital General Universitario de Valencia, Valencia Switzerland
University Hospital Basel, Basel Kantonsspital Winterthur, Winterthur